Back
Immuneering Stock Predictions
Sponsored
IMRX
Sponsored
Trump wins! Dow to 75,000? Details here
See the explosive "Document 20" details here.
Sell
31
IMRX
Immuneering
Last Price:
1.70
Seasonality Move:
-29.24%
7 Day Trial
ALL ACCESS PASS
$
7
U.S. Government Report Alert Tuesday
Discover the Secret LoopholeImmuneering Stock Forecast
-
Is Immuneering Stock Undervalued?
The current Immuneering [IMRX] share price is $1.83. The Score for IMRX is 31, which is 38% below its historic median score of 50, and infers higher risk than normal. - IMRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
Will Immuneering Stock Go Up Next Year?
Data Unavailable
Immuneering Stock Rating
Data Unavailable
Immuneering Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
immuneering.com
52-Week Data
52-Week High:
8.89
52-Week Low:
1.00
Prediction Charts
Market Cap:
54.27M
Price in USD:
1.83
Volume:
217.9K
Beta:
-0.40
Technical Analysis
SMA50:
2.13
SMA100:
1.66
SMA200:
2.42
52-Wk Change:
-64.71%
Stock Predictions
-
Is Immuneering stock public?
Yes, Immuneering is a publicly traded company. -
What is the Immuneering stock quote today?
The Immuneering stock price is 1.83 USD today. -
How to buy Immuneering stock online?
You can buy Immuneering shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Oct-24 | 2.16 | 2.15 | 2.21 | 2.07 |
Oct-25 | 2.13 | 2.01 | 2.16 | 2.01 |
Oct-28 | 2.01 | 2.14 | 2.16 | 2.01 |
Oct-29 | 2.16 | 1.98 | 2.16 | 1.97 |
Oct-30 | 2.00 | 1.92 | 2.00 | 1.92 |
Oct-31 | 1.90 | 1.86 | 1.93 | 1.81 |
Nov-1 | 1.88 | 1.87 | 1.95 | 1.84 |
Nov-4 | 1.84 | 1.86 | 1.91 | 1.83 |
Nov-5 | 1.86 | 1.96 | 1.98 | 1.86 |
Nov-6 | 2.00 | 1.92 | 2.02 | 1.89 |
Nov-7 | 1.92 | 1.93 | 1.99 | 1.90 |
Nov-8 | 1.95 | 1.90 | 1.95 | 1.80 |
Nov-11 | 1.84 | 1.90 | 1.97 | 1.83 |
Nov-12 | 1.90 | 1.83 | 1.90 | 1.80 |
Immuneering Earnings
Data Unavailable
Immuneering Forecast Revenue Growth
Data Unavailable
- Analysts estimate an earnings increase this quarter of $0.17 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and an increase next year of $0.20 per share.
* Immuneering stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.